Literature DB >> 19254043

Controlling cervical cancer.

Maurizio Bonati, Silvio Garattini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19254043     DOI： 10.2165/00019053-200927020-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  24 in total

Review 1.  Evaluation of cervical cytology.

Authors:  D C McCrory; D B Matchar; L Bastian; S Datta; V Hasselblad; J Hickey; E Myers; K Nanda
Journal:  Evid Rep Technol Assess (Summ)       Date:  1999-01

2.  Human papillomavirus vaccination--reasons for caution.

Authors:  Charlotte J Haug
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

3.  The theoretical population-level impact of a prophylactic human papilloma virus vaccine.

Authors:  James P Hughes; Geoff P Garnett; Laura Koutsky
Journal:  Epidemiology       Date:  2002-11       Impact factor: 4.822

4.  Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus.

Authors:  H zur Hausen; W Meinhof; W Scheiber; G W Bornkamm
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

Review 5.  Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.

Authors:  Thomas C Wright; F Xavier Bosch; Eduardo L Franco; Jack Cuzick; John T Schiller; Geoffrey P Garnett; André Meheus
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

Review 6.  Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.

Authors:  Erik J Dasbach; Elamin H Elbasha; Ralph P Insinga
Journal:  Epidemiol Rev       Date:  2006-06-01       Impact factor: 6.222

Review 7.  Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.

Authors:  Jill Koshiol; Lisa Lindsay; Jeanne M Pimenta; Charles Poole; David Jenkins; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2008-05-15       Impact factor: 4.897

Review 8.  Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.

Authors:  F Xavier Bosch; Ann N Burchell; Mark Schiffman; Anna R Giuliano; Silvia de Sanjose; Laia Bruni; Guillermo Tortolero-Luna; Susanne Kruger Kjaer; Nubia Muñoz
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

9.  Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.

Authors:  S Deblina Datta; Laura A Koutsky; Sylvie Ratelle; Elizabeth R Unger; Judith Shlay; Tracie McClain; Beth Weaver; Peter Kerndt; Jonathan Zenilman; Michael Hagensee; Cristen J Suhr; Hillard Weinstock
Journal:  Ann Intern Med       Date:  2008-04-01       Impact factor: 25.391

10.  Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.

Authors:  Ruanne V Barnabas; Päivi Laukkanen; Pentti Koskela; Osmo Kontula; Matti Lehtinen; Geoff P Garnett
Journal:  PLoS Med       Date:  2006-04-04       Impact factor: 11.069
View more
  1 in total

Review 1.  Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.

Authors:  Daniela Koleva; Paola De Compadri; Anna Padula; Livio Garattini
Journal:  Intern Emerg Med       Date:  2011-02-11       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.